Pre-exposure Prophylaxis (PrEP) Adherence Intervention for Women with Substance Use Disorders (NCT06158607)
Development and Pilot Testing of an Addiction Clinic-Based PrEP Adherence Intervention for Women with Substance Use Disorders
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to test an addiction-clinic based behavioral intervention for increasing PrEP uptake and adherence among women who engage in high-risk sexual behaviors and problematic substance use. The main question it aims to answer is: • If the integrated intervention increase PrEP uptake and adherence compared to standard treatment Participants will * receive provision of PrEP information through 4 counseling sessions * prevention navigation * receive nurse practitioner prescribed PrEP in an addiction treatment setting Researchers will compare intervention group with standard treatment to see if the integrated intervention help increase PrEP uptake and adherence
Who can join: Review the eligibility criteria below.
Location: Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston — Houston, Texas
Age range: 18 Years to 60 Years
🧪 Interventions in This Study
- Addiction Clinic-Based PrEP Adherence Intervention for Women with Substance Use Disorders (BEHAVIORAL)
- Standard of care treatment (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston — Houston, Texas
📞 Contact the Study Coordinator
Phone: (713) 486-2830
Email: Angela.M.Heads@uth.tmc.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Substance Use
- The Substance Abuse Treatment to HIV Care II (SAT2HIV-II) Project — Columbus, Ohio
- Expanding the Potential of Couples HIV Testing: Adjunct Modules to Reduce Drug Use Among Vulnerable Male Couples — Ann Arbor, Michigan
- Substance Use Treatment and Its Role in Supporting Social Cognition — Fort Lauderdale, Florida
- Collaborative Care for Polysubstance Use in Primary Care Settings (Co-Care) — Torrance, California
- Developing a Telehealth Model to Improve Treatment Access for Rural Veterans With Substance Use Disorders — Ann Arbor, Michigan
- Community Driven Substance Use Recovery for High Opioid Overdose Areas — Bridgeport, Connecticut
Explore by condition: All Substance Use clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.